5 Cheap Dividend Stocks for Prudent Investors

5 Cheap Dividend Stocks for Prudent InvestorsValue investors buy stocks of companies that appear to be priced below their intrinsic values based on financial metrics such as price-to-earnings ratios, price-to-book ratios, or dividend yields. A value investment strategy has proven to produce greater risk-adjusted returns than alternatives. Prudent value investors can attempt to achieve higher returns by uncovering undervalued companies that boast an appreciation potential and dividend payouts that provide current income.

Nuveen Dividend Value A (MUTF:FFEIX), ranked by Barron’s as one of the top dividend funds, consists of 89 stocks of high-quality, dividend-paying companies with above average current income or dividend growth, and a value bias. While the fund’s largest holdings include mega caps such as Pfizer Inc. (NYSE:PFE), Verizon Communications Inc. (NYSE:VZ), and Chevron Corporation (NYSE:CVX), they also include some less-known dividend plays that represent attractive value and income investments. Here is a closer look at the fund’s five value dividend stocks with yields exceeding the average yield on the S&P 500 index.

Maxim Integrated Products Inc. (NASDAQ:MXIM) is an $8.6-billion producer of linear and mixed-signal integrated circuits. It is a dividend achiever that has raised dividends uninterruptedly since 2003. The chipmaker pays a dividend yield of 3.2% on a payout ratio of 76% of trailing earnings and 59% of free cash flow. Over the past five years, its dividend grew, on average, by 6% annually. This year, the company hiked its dividend by a larger-than-average 9.1%. The company’s dividend growth is likely to be sustained as its EPS CAGR is forecast to accelerate to 13.5% for the next five years, double the rate over the past five years. Maxim’s business is driven by the fast-growing smartphone market. In fact, the company is a leading supplier for Samsung’s Galaxy S III, which has seen explosive growth. Maxim is a major producer of mixed signal and analog integrated circuits, which are expected to grow faster than other chip segments. The company has no long-term debt. With a forward P/E of 16.4x, Maxim’s stock is discounted relative to its respective industry (forward P/E of 16.8x). Billionaire fund managers Jim Simons and Ken Griffin are bullish about this stock.

Westar Energy Inc (NYSE:WR), with a market capitalization of $3.7 billion, is the largest electric utility in Kansas. Currently, its dividend yields a high 4.5% on a payout ratio of 67%. The utility has raised dividends for seven consecutive years. Its dividend grew, on average, by 4.1% per year over the past five years. Westar Energy’s EPS CAGR is forecast to accelerate to 6.6% for the next five years from a mere 0.7% per year achieved over the past five years. The utility’s forward P/E of 13.9x is below its respective industry’s average ratio of 15.4x. Its dividend is higher than the average for its industry. The company is growing through diversification of energy supply sources and building of transmission capacity. Westar Energy is popular with RenTech’s Jim Simons.

AFLAC Incorporated (NYSE:AFL) is $26-billion supplemental health and life insurance provider in Japan and the United States. It is Japan’s largest insurance company in terms of individual insurance policies. The company is a dividend aristocrat that has boosted dividends for 30 consecutive years. Its dividend yield is 2.6% on a low payout ratio of 23%. Aflac’s dividend growth over the past five years averaged nearly 11% per year. Given its low payout ratio and the forecasted EPS CAGR of 10.2% for the next five years (faster than 7.2% achieved over the past five years), dividend growth is likely to be sustained. Aflac derives 83% of its revenues from Japan, where it is experiencing robust growth. It is holding substantial yen-denominated assets. However, in recent years, Aflac has been building up its investment position in U.S government and corporate bonds. The U.S. Affordable Care Act requirement that all U.S. citizens have health insurance will likely bolster the insurance provider’s growth in the U.S. market. Aflac has a strong balance sheet, with little debt, and is a robust cash flow generator. Notwithstanding its trading close to a 52-week high, Aflac’s stock has a low P/E of 8.0x, on par with the life insurance industry. Citadel Investment’s Ken Griffin is particularly bullish about Alfac.

Occidental Petroleum Corporation (NYSE:OXY) is a $64-billion integrated oil and natural gas producer. The company has raised dividends each year since 2002. Its dividend is yielding 2.8% on a payout ratio of 30%. Occidental Petroleum has seen robust dividend growth, averaging 18.1% annually over the past five years. The firm’s revenue growth is expected to resume next year with a 5% sales increase. For the next five years, its EPS CAGR will average about 9%. The stock is trading well below its five-year valuation metrics such as price-to-book, price-to-sales, and price-to-cash flow. With a forward P/E of 11.0x, the stock is at a discount to its respective industry (forward P/E of 14.1x). Its rival Exxon Mobil Corporation (NYSE:XOM) forward P/E is almost on par with that of OXY, while Chevron Corporation (CVX) is cheaper than OXY based on the same metric. Among fund managers, Ric Dillon (Diamond Hill Capital—check out its top picks) and Relational Investors’ Ralph Whitworth are big investors in the stock.

Allegheny Technologies Incorporated (NYSE:ATI) is a $3.2-billion specialty metals producer with customers in the aerospace, defense, automotive, and medical industries. The company’s dividend is yielding 2.4% on a payout ratio of 44%. Its dividend has been flat at $0.18 per share since 2007. Analyst forecast the company’s EPS CAGR at 15%, which is highly dependent on the global economic rebound. The company remains optimistic about it long-term growth prospects, in particular in China. However, it is dependent on raw materials, whose elevated prices remain a source of pressure on the company’s performance. ATI is trading at price-to-book, price-to-sales, and price-to-cash flow ratios well below industry averages. However, with a forward P/E of 19.1x, the stock is quite expensive relative to its peer group on average (forward P/E of 14.4x). Billionaire Jim Simons is a buyer of this stock.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!